Complement regulation of T cell immunity.

Bacillus anthracis Spore Surface Protein BclA Mediates Complement Factor H Binding to Spores and Promotes Spore Persistence. PLoS Pathog (2016) 1.40

Complement activation in the injured central nervous system: another dual-edged sword? J Neuroinflammation (2012) 1.11

Regulatory cells and transplantation tolerance. Cold Spring Harb Perspect Med (2013) 0.86

STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy. EMBO Mol Med (2013) 0.85

Complement regulation of T-cell alloimmunity. Semin Nephrol (2013) 0.81

Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation. Front Immunol (2016) 0.78

Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components. PLoS One (2014) 0.78

Complement and macrophage crosstalk during process of angiogenesis in tumor progression. J Biomed Sci (2015) 0.78

Complement factor H in host defense and immune evasion. Cell Mol Life Sci (2016) 0.78

Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain (2016) 0.77

Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus. J Immunol (2016) 0.75

The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches. J Immunol Res (2016) 0.75

Pathways analysis of differential gene expression induced by engrafting doses of total body irradiation for allogeneic bone marrow transplantation in mice. Immunogenetics (2013) 0.75

To drive or be driven: the path of a mouse model of recurrent pregnancy loss. Reproduction (2014) 0.75

Properdin and factor H production by human dendritic cells modulates their T-cell stimulatory capacity and is regulated by IFN-γ. Eur J Immunol (2017) 0.75

Adipsin Is Associated with Multiple Sclerosis: A Follow-Up Study of Adipokines. Mult Scler Int (2015) 0.75

Loss of Peripheral Tolerance in Emphysema. Phenotypes, Exacerbations, and Disease Progression. Ann Am Thorac Soc (2015) 0.75

Targeted complement inhibition protects vascularized composite allografts from acute graft injury and prolongs graft survival when combined with subtherapeutic cyclosporine A therapy. Transplantation (2016) 0.75

Production of complement components by cells of the immune system. Clin Exp Immunol (2017) 0.75

Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective. Clin Exp Immunol (2015) 0.75

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature (1998) 12.70

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature (1998) 12.07

Complement: a key system for immune surveillance and homeostasis. Nat Immunol (2010) 10.37

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med (1984) 5.47

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science (1996) 4.35

Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med (2002) 3.39

Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity (2008) 3.36

Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood (2008) 2.91

Decay-accelerating factor modulates induction of T cell immunity. J Exp Med (2005) 2.34

C3 polymorphisms and allograft outcome in renal transplantation. N Engl J Med (2009) 2.29

Role of complement in the induction of immunological responses. Transplant Rev (1976) 2.21

The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J Exp Med (2005) 2.09

Influence of donor C3 allotype on late renal-transplantation outcome. N Engl J Med (2006) 1.97

C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J Am Soc Nephrol (2009) 1.85

Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol (1999) 1.77

CD4+ but not CD8+ cells are essential for allorejection. J Exp Med (1996) 1.72

Complement 5a receptor inhibition improves renal allograft survival. J Am Soc Nephrol (2008) 1.72

Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J Exp Med (2010) 1.62

Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production. J Immunol (2007) 1.59

Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes (2010) 1.57

Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection. J Immunol (2003) 1.56

IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production. J Immunol (2008) 1.45

Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood (2008) 1.33

Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection. J Immunol (2008) 1.28

Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation. Am J Transplant (2009) 1.27

Dendritic cell function in allostimulation is modulated by C5aR signaling. J Immunol (2009) 1.24

Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice. J Immunol (2007) 1.20

Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol (2009) 1.16

Antibody and complement in transplant vasculopathy. Circ Res (2007) 1.12

Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J (2007) 1.11

C6 produced by macrophages contributes to cardiac allograft rejection. Am J Pathol (1999) 0.98

Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells. J Clin Invest (2009) 0.96

Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection. Am J Pathol (2011) 0.93

Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury. Transplantation (2008) 0.93

Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice. Am J Transplant (2011) 0.90

Decay accelerating factor is essential for successful corneal engraftment. Am J Transplant (2010) 0.87

Complement in transplant rejection: diagnostic and mechanistic considerations. Springer Semin Immunopathol (2003) 0.83

Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40

Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity (2008) 3.36

Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood (2008) 2.91

Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol (2009) 2.87

Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat Immunol (2002) 2.25

Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant (2002) 2.18

Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A (2009) 1.95

Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation. J Exp Med (2011) 1.78

T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J Immunol (2002) 1.73

Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. Am J Transplant (2005) 1.60

Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production. J Immunol (2007) 1.59

CD8 T cells can reject major histocompatibility complex class I-deficient skin allografts. Am J Transplant (2004) 1.57

Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes (2010) 1.57

Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. Transplantation (2007) 1.50

Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J Exp Med (2013) 1.48

Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant (2003) 1.47

Biosensors from conjugated polyelectrolyte complexes. Proc Natl Acad Sci U S A (2001) 1.46

IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production. J Immunol (2008) 1.45

In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J Immunol (2004) 1.45

Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant (2002) 1.38

Panel of reactive T cells as a measurement of primed cellular alloimmunity in kidney transplant candidates. J Am Soc Nephrol (2005) 1.37

Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells. J Immunol (2005) 1.32

Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection. J Immunol (2008) 1.28

Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. J Immunol (2006) 1.23

Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy. J Am Soc Nephrol (2004) 1.22

HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens. AIDS (2002) 1.15

Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells. J Immunol (2013) 1.13

Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots. Transplantation (2008) 1.11

The male minor transplantation antigen preferentially activates recipient CD4+ T cells through the indirect presentation pathway in vivo. J Immunol (2003) 1.09

Antigen-presenting cell-derived complement modulates graft-versus-host disease. J Clin Invest (2012) 1.09

TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection. J Immunol (2007) 1.08

Effects of T cell frequency and graft size on transplant outcome in mice. J Immunol (2004) 1.05

Effects of influenza immunization on humoral and cellular alloreactivity in humans. Transplantation (2010) 1.02

Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants. J Immunol (2002) 0.99

Hemodialysis vintage, black ethnicity, and pretransplantation antidonor cellular immunity in kidney transplant recipients. J Am Soc Nephrol (2007) 0.99

Graft-derived complement as a mediator of transplant injury. Curr Opin Immunol (2007) 0.97

Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients. J Immunol (2011) 0.96

Donor factors influencing graft outcomes in live donor kidney transplantation. Transplantation (2007) 0.94

Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury. Transplantation (2008) 0.93

The relative contribution of direct and indirect antigen recognition pathways to the alloresponse and graft rejection depends upon the nature of the transplant. Hum Immunol (2002) 0.93

Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection. Am J Pathol (2011) 0.93

Novel aspects of complement in kidney injury. Kidney Int (2009) 0.92

Antibodies reactive to non-HLA antigens in transplant glomerulopathy. J Am Soc Nephrol (2011) 0.91

T-cell immune monitoring in organ transplantation. Curr Opin Organ Transplant (2008) 0.91

Mouse endothelial cells cross-present lymphocyte-derived antigen on class I MHC via a TAP1- and proteasome-dependent pathway. J Immunol (2005) 0.90

Targeting complement component 5a promotes vascular integrity and limits airway remodeling. Proc Natl Acad Sci U S A (2013) 0.90

Emerging roles of endothelial cells in transplant rejection. Curr Opin Immunol (2003) 0.90

Complement as a multifaceted modulator of kidney transplant injury. J Clin Invest (2014) 0.89

Comprehensive determinant mapping of the hepatitis C-specific CD8 cell repertoire reveals unpredicted immune hierarchy. Clin Immunol (2002) 0.89

Heterogeneous alterations in human alloimmunity associated with immunization. Transplantation (2005) 0.89

Development of autoimmunity after skin graft rejection via an indirect alloresponse. Transplantation (2002) 0.87

Analysis of immune markers in human cardiac allograft recipients and association with coronary artery vasculopathy. J Heart Lung Transplant (2005) 0.86

Antigen location contributes to the pathological features of a transplanted heart graft. Am J Pathol (2004) 0.85

CD8 T cells specific for a donor-derived, self-restricted transplant antigen are nonpathogenic bystanders after vascularized heart transplantation in mice. J Immunol (2006) 0.84

Effects of preexisting autoimmunity on heart graft prolongation after donor-specific transfusion and anti-CD154. Transplantation (2014) 0.84

Effects of green tea polyphenols on murine transplant-reactive T cell immunity. Clin Immunol (2004) 0.82

Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidates. Clin Transplant (2012) 0.82

Effects of cellular sensitization and donor age on acute rejection and graft function after deceased-donor kidney transplantation. Transplantation (2013) 0.82

Complement regulation of T-cell alloimmunity. Semin Nephrol (2013) 0.81

Locally produced and activated complement as a mediator of alloreactive T cells. Front Biosci (Schol Ed) (2009) 0.81

Immunologic monitoring in transplantation revisited. Curr Opin Organ Transplant (2012) 0.81

Effects of complement activation on allograft injury. Curr Opin Organ Transplant (2015) 0.79

Complement regulation of T-cell alloimmunity. Curr Opin Organ Transplant (2011) 0.78

Proteomic portrayal of transplant pathologies. J Am Soc Nephrol (2009) 0.77

Gazing into a crystal ball to predict kidney transplant outcome. J Clin Invest (2010) 0.77

Cardiac allograft rejection in the absence of macrophage migration inhibitory factor. Transplantation (2003) 0.76

Effect of Absent Immune Cell Expression of Vitamin D Receptor on Cardiac Allograft Survival in Mice. Transplantation (2015) 0.75

Sequestration and suppression of anti-HLA antibodies by a failed kidney allograft. Clin J Am Soc Nephrol (2012) 0.75

Transplantation: Complementing donor-specific antibody testing. Nat Rev Nephrol (2013) 0.75

T-cell immune monitoring in organ transplantation. Transplantation (2009) 0.75

Immune monitoring in kidney transplant recipients revisited. J Am Soc Nephrol (2002) 0.75

Corrigendum. Complement as a multifaceted modulator of kidney transplant injury. J Clin Invest (2015) 0.75

Correction: The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells. J Exp Med (2017) 0.75

Role of Circulating microRNAs in the Immunopathogenesis of Rejection Following Pediatric Lung Transplantation. Transplantation (2016) 0.75